{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:33Z","timestamp":1791407373892,"version":"4.3.3"},"reference-count":354,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD) is the most common form of dementia. The risk of AD increases with age. Although two of the main pathological features of AD, amyloid plaques and neurofibrillary tangles, were already recognized by Alois Alzheimer at the beginning of the 20th century, the pathogenesis of the disease remains unsettled. Therapeutic approaches targeting plaques or tangles have not yet resulted in satisfactory improvements in AD treatment. This may, in part, be due to early-onset and late-onset AD pathogenesis being underpinned by different mechanisms. Most animal models of AD are generated from gene mutations involved in early onset familial AD, accounting for only 1% of all cases, which may consequently complicate our understanding of AD mechanisms. In this article, the authors discuss the pathogenesis of AD according to the two main neuropathologies, including senescence-related mechanisms and possible treatments using stem cells, namely mesenchymal and neural stem cells.<\/jats:p>","DOI":"10.3390\/ijms161125961","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T10:46:46Z","timestamp":1446634006000},"page":"26417-26451","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Alzheimer\u2019s Disease: Mechanism and Approach to Cell Therapy"],"prefix":"10.3390","volume":"16","author":[{"given":"Takashi","family":"Amemori","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4644-9212","authenticated-orcid":false,"given":"Pavla","family":"Jendelova","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic"},{"name":"Department of Neuroscience, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague 5, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Ruzicka","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Urdzikova","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sykova","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 20 Prague 4, Czech Republic"},{"name":"Department of Neuroscience, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague 5, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/science.273.5271.28","article-title":"Auguste D. and Alzheimer\u2019s disease","volume":"273","year":"1996","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neurobiolaging.2005.05.022","article-title":"Intraneuronal A\u03b2 accumulation and origin of plaques in Alzheimer\u2019s disease","volume":"26","author":"Gouras","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/brain\/awn256","article-title":"Oskar Fischer and the study of dementia","volume":"132","author":"Goedert","year":"2009","journal-title":"Brain"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(96)10203-8","article-title":"Augaste D and Alzheimer\u2019s disease","volume":"349","author":"Maurer","year":"1997","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s100480050011","article-title":"Rediscovery of the case described by Alois Alzheimer in 1911: Historical, histological and molecular genetic analysis","volume":"1","author":"Graeber","year":"1997","journal-title":"Neurogenetics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s100480050033","article-title":"Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D","volume":"1","author":"Graeber","year":"1998","journal-title":"Neurogenetics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(12)70307-1","article-title":"A presenilin 1 mutation in the first case of Alzheimer\u2019s disease","volume":"12","author":"Muller","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jalz.2014.06.005","article-title":"A presenilin 1 mutation in the first case of Alzheimer\u2019s disease: Revised","volume":"10","author":"Rupp","year":"2014","journal-title":"Alzheimers Dement."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer\u2019s disease: Past, present and future","volume":"76","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bcp.2014.01.003","article-title":"Future direction in Alzheimer\u2019s disease from risk factors to prevention","volume":"88","author":"Imtiaz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e35133","DOI":"10.1371\/journal.pone.0035133","article-title":"Alzheimer\u2019s disease-linked mutations in presenilin-1 result in a drastic loss of activity in purified \u03b3-secretase complexes","volume":"7","author":"Cacquevel","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt59","article-title":"Autosonal-dominant Alzheimer\u2019s disease: A review and proposal for the prevention of Alzheimer\u2019s disease","volume":"3","author":"Bateman","year":"2011","journal-title":"Alzheimers Res. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer\u2019s disease increase production of 42-residue amyloid \u03b2-protein in both transfected cells and transgenic mice","volume":"3","author":"Citron","year":"1997","journal-title":"Nat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: Genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2011.12.057","article-title":"Role of mitochondrial homeostasis and dynamics in Alzheimer\u2019s disease","volume":"51","author":"Selfridge","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.1996.tb34412.x","article-title":"Apolipoprotein E. Structure, function, and possible roles in Alzheimer\u2019s disease","volume":"777","author":"Mahley","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: Far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1194\/jlr.R300017-JLR200","article-title":"Functions of lipoprotein receptors in neurons","volume":"45","author":"Beffert","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1582-4934.2007.00130.x","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: Molecular mechanisms and therapeutic opportunities","volume":"11","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","article-title":"Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease","volume":"47","author":"Roses","year":"1996","journal-title":"Annu. Rev. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","article-title":"The genetics of Alzheimer\u2019s disease","volume":"107","author":"Bertram","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archneur.55.7.964","article-title":"Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam study","volume":"55","author":"Slooter","year":"1988","journal-title":"Arch. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nn.2584","article-title":"Genome-wide association studies: The key to unlocking neurodegeneration?","volume":"13","author":"Gandhi","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/mp.2013.1","article-title":"Increased expression of BIN1 mediates Alzheimer genetic risk by modulating Tau pathology","volume":"18","author":"Chapuis","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/gm249","article-title":"The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer\u2019s disease","volume":"3","author":"Boada","year":"2011","journal-title":"Genome Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: Altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid \u03b2","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e50976","DOI":"10.1371\/journal.pone.0050976","article-title":"Expression of novel Alzheimer\u2019s disease risk genes in control and Alzheimer\u2019s disease brains","volume":"7","author":"Karch","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e58618","DOI":"10.1371\/journal.pone.0058618","article-title":"SORL1 is genetically associated with late-onset Alzheimer\u2019s disease in Japanese, Koreans and Caucasians","volume":"8","author":"Miyashita","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","article-title":"Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer\u2019s disease","volume":"5","author":"Jones","year":"2010","journal-title":"PLoS ONE"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00023.2009","article-title":"Proteases and proteolysis in Alzheimer disease: A multifactorial view on the disease process","volume":"90","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"de la Monte, S. (2011). Alzheimer\u2019s Disease Pathogenesis\u2014Core Concepts, Shifting Paradigms and Therapeutic Targets, InTech.","DOI":"10.5772\/951"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature07767","article-title":"APP binds DR6 to trigger axon pruning and neuron death via distinct caspases","volume":"457","author":"Nikolaev","year":"2009","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Higgins, G.A. Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid \u03b2-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-\u03b2 protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13506120500106958","article-title":"Neurotoxic protein oligomers\u2014What you see is not always what you get","volume":"12","author":"Bitan","year":"2005","journal-title":"Amyloid"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid \u03b2 oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","article-title":"Alkon, D.L. Role of insulin and insulin receptor in learning and memory","volume":"177","author":"Zhao","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1523\/JNEUROSCI.6500-10.2011","article-title":"Alzheimer\u2019s disease brain-derived amyloid-\u03b2-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein","volume":"31","author":"Barry","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.3178","article-title":"Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons","volume":"15","author":"Um","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid \u03b2-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.3233\/JAD-2012-129001","article-title":"Molecular mechanisms of amyloid oligomers toxicity","volume":"33","author":"Kayed","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1111\/j.1582-4934.2008.00509.x","article-title":"mTOR-dependent signalling in Alzheimer\u2019s disease","volume":"12","author":"Pei","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/mp.2008.115","article-title":"Immunization in Alzheimer\u2019s disease: Naive hope or realistic clinical potential?","volume":"14","author":"Foster","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jalz.2011.09.224","article-title":"Safety and biomarker effects of solanezumab in patients with Alzheimer\u2019s disease","volume":"8","author":"Farlow","year":"2012","journal-title":"Alzheimers Dement."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/alzrt272","article-title":"Targeting the proper amyloid-\u03b2 neuronal toxins: A path forward for Alzheimer\u2019s disease immunotherapeutics","volume":"6","author":"Goure","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Alzheimer\u2019s Disease Cooperative Study Steering Committee, Solanezumab Study Group. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Siemers, E.R., Sundell, K.L., Carlson, C., Case, M., Sethuraman, G., Liu-Seifert, H., Dowsett, S.A., Pontecorvo, M.J., Dean, R.A., and Demattos, R. (2015). Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer\u2019s disease patients. Alzheimers Dement.","DOI":"10.1016\/j.jalz.2015.06.1893"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bcp.2013.12.020","article-title":"Immunotherapy for Alzheimer\u2019s disease","volume":"88","author":"Wisniewski","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","article-title":"Can we prevent Alzheimer\u2019s disease? Secondary \u201cprevention\u201d trials in Alzheimer\u2019s disease","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/S0021-9258(17)42989-9","article-title":"Phosphorylation affects the ability of Tau protein to promote microtubule assembly","volume":"259","author":"Lindwall","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/343461a0","article-title":"Inhibition of neurite polarity by Tau antisense oligonucleotides in primary cerebellar neurons","volume":"343","author":"Caceres","year":"1990","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","article-title":"Mutation-specific functional impairments in distinct Tau isoforms of hereditary FTDP-17","volume":"282","author":"Hong","year":"1998","journal-title":"Science"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0955-0674(00)00172-1","article-title":"Going new places using an old MAP: Tau, microtubules and human neurodegenerative disease","volume":"13","author":"Garcia","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease","volume":"41","author":"Hollister","year":"1997","journal-title":"Ann. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived Tau oligomers propagate pathology from endogenous Tau","volume":"2","author":"Sengupta","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1523\/JNEUROSCI.0587-07.2007","article-title":"Accumulation of pathological Tau species and memory loss in a conditional model of tauopathy","volume":"27","author":"Berger","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","article-title":"Tau protein as a differential biomarker of tauopathies","volume":"1739","author":"Sergeant","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_77","first-page":"1159","article-title":"Localization of disinhibition\u2013dementia\u2013parkinsonism\u2013amyotrophy complex to 17q2-22","volume":"55","author":"Wilhelmsen","year":"1994","journal-title":"Am. J. Hum. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.20539","article-title":"Tau gene mutations and their effects","volume":"12","author":"Goedert","year":"2005","journal-title":"Mov. Disord."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking A\u03b2 and Tau in late-onset Alzheimer\u2019s disease: A dual pathway hypothesis","volume":"60","author":"Small","year":"2008","journal-title":"Neuron"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bcp.2014.01.009","article-title":"The complexities of the pathology\u2014pathogenesis relationship in Alzheimer disease","volume":"88","author":"Castellani","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of A\u03b242 immunisation in Alzheimer\u2019s disease: Follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.63.10.1459","article-title":"Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal Tau protein","volume":"63","author":"Rosenmann","year":"2006","journal-title":"Arch. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","article-title":"Passive immunization targeting pathological phospho-Tau protein in a mouse model reduces functional decline and clears Tau aggregates from the brain","volume":"118","author":"Boutajangout","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"34457","DOI":"10.1074\/jbc.M111.229633","article-title":"Passive immunization with anti-Tau antibodies in two transgenic models: Reduction of Tau pathology and delay of disease progression","volume":"286","author":"Chai","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2013.12.018","article-title":"The role of amyloid-\u03b2 in the regulation of memory","volume":"88","author":"Morley","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Muller, U.C., and Zheng, H. (2012). Physiological functions of APP family proteins. Cold Spring Harb. Perspect. Med., 2.","DOI":"10.1101\/cshperspect.a006288"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Ke, Y.D., Suchowerska, A.K., van der Hoven, J., de Silva, D.M., Wu, C.W., van Eersel, J., Ittner, A., and Ittner, L.M. (2012). Lessons from Tau-deficient mice. Int. J. Alzheimers Dis., 2012.","DOI":"10.1155\/2012\/873270"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Taylor, R.C., and Dillin, A. (2011). Aging as an event of proteostasis collapse. Cold Spring Harb. Perspect. Biol., 3.","DOI":"10.1101\/cshperspect.a004440"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"74","author":"Schroder","year":"2005","journal-title":"Annu. Rev. Biochem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1016\/j.bbamcr.2013.07.024","article-title":"When ER stress reaches a dead end","volume":"1833","author":"Urra","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1742-2094-6-41","article-title":"ER stress in Alzheimer\u2019s disease: A novel neuronal trigger for inflammation and Alzheimer\u2019s pathology","volume":"6","author":"Salminen","year":"2009","journal-title":"J. Neuroinflamm."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1083\/jcb.200904060","article-title":"Role of ERO1-\u03b1-mediated stimulation of inositol 1,4,5-tirphoate receptor activity in endoplasmic reticulum stress-induced apoptosis","volume":"186","author":"Li","year":"2009","journal-title":"J. Cell Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.287.5453.664","article-title":"Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1","volume":"287","author":"Urano","year":"2000","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/156652406775574541","article-title":"The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases","volume":"6","author":"Sekine","year":"2006","journal-title":"Curr. Mol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/j.1471-4159.2007.04930.x","article-title":"Kinase activities increase during the development of tauopathy in htau mice","volume":"103","author":"Kelleher","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-2011-110320","article-title":"JNK plays a key role in Tau hyperphosphorylation in Alzheimer\u2019s disease models","volume":"26","author":"Ploia","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cuanalo-Contreras, K., Mukherjee, A., and Soto, C. (2013). Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int. J. Cell Biol., 2013.","DOI":"10.1155\/2013\/638083"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-kappaB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pneurobio.2006.06.001","article-title":"Transcriptional and translational regulation of BACE1 expression\u2014Implications for Alzheimer\u2019s disease","volume":"79","author":"Rossner","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.freeradbiomed.2008.03.012","article-title":"Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease","volume":"44","author":"Resende","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12035-012-8246-0","article-title":"Protein homeostasis, aging and Alzheimer\u2019s disease","volume":"46","author":"Morawe","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1096\/fj.01-0530fje","article-title":"Microglial activation and amyloid-\u03b2 clearance induced by exogenous heat-shock proteins","volume":"16","author":"Kakimura","year":"2002","journal-title":"FASEB J."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1582-4934.2008.00557.x","article-title":"Chaperone signalling complexes in Alzheimer\u2019s disease","volume":"13","author":"Koren","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12035-007-0029-7","article-title":"Heat shock proteins and amateur chaperones in amyloid-\u03b2 accumulation and clearance in Alzheimer\u2019s disease","volume":"35","author":"Wilhelmus","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"16798","DOI":"10.1074\/jbc.M110.113753","article-title":"Hsc70 rapidly engages Tau after microtubule destabilization","volume":"285","author":"Jinwal","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1471-4159.2005.03272.x","article-title":"In vivo evidence of CHIP up-regulation attenuating Tau aggregation","volume":"94","author":"Sahara","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1073\/pnas.0709180105","article-title":"Akt and CHIP coregulate Tau degradation through coordinated interactions","volume":"105","author":"Dickey","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbalip.2010.03.011","article-title":"Brain cholesterol in normal and pathological aging","volume":"1801","author":"Martin","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tem.2013.10.003","article-title":"What are lipoproteins doing in the brain?","volume":"25","author":"Wang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0197-4580(02)00018-0","article-title":"Brain membrane cholesterol domains, aging and amyloid \u03b2-peptides","volume":"23","author":"Wood","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"193618","DOI":"10.4061\/2011\/193618","article-title":"The pathological roles of ganglioside metabolism in Alzheimer\u2019s disease: Effects of gangliosides on neurogenesis","volume":"2011","author":"Ariga","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"24985","DOI":"10.1074\/jbc.M100252200","article-title":"Cholesterol-dependent formation on GM1 ganglioside-bound amyloid \u03b2-protein, an endogenous seed for Alzheimer amyloid","volume":"276","author":"Kakio","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fphys.2013.00120","article-title":"Cholesterol accelerates the binding of Alzheimer\u2019s \u03b2-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation","volume":"4","author":"Fantini","year":"2013","journal-title":"Front. Physiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2010.06.080","article-title":"Sphingomyelin accumulation provides a favorable milieu for GM1 ganglioside-induced assembly of amyloid \u03b2-protein","volume":"481","author":"Yuyama","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn2059","article-title":"Lipid raft microdomains and neurotransmitter signalling","volume":"8","author":"Allen","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.febslet.2007.03.019","article-title":"Lipid rats and membrane traffic","volume":"581","author":"Hancock","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09687860500496417","article-title":"The involvement of lipid rafts in Alzheimer\u2019s disease","volume":"23","author":"Cordy","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1073\/pnas.081612998","article-title":"Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the \u03b1-secretase ADAM 10","volume":"98","author":"Kojro","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer \u03b2-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fphys.2012.00189","article-title":"Lipid rafts and Alzheimer\u2019s disease: Protein\u2013lipid interactions and perturbation of signaling","volume":"3","author":"Hicks","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1471-4159.2010.07070.x","article-title":"Plasmalogen synthesis is regulated via alkyl-dihydorxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer\u2019s disease","volume":"116","author":"Grimm","year":"2011","journal-title":"J. Neurochem."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Rothhaar, T.L., Grosgen, S., Haupenthal, V.J., Burg, V.K., Hundsdorfer, B., Mett, J., Riemenschneider, M., Grimm, H.S., Hartmann, T., and Grimm, M.O. (2012). Plasmalogens inhibit APP processing by directly affecting \u03b3-secretase activity in Alzheimer\u2019s disease. Sci. World J., 2012.","DOI":"10.1100\/2012\/141240"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"18367","DOI":"10.1073\/pnas.0907652106","article-title":"Alzheimer\u2019s disease-like pathological features in transgenic mice expressing the APP intracellular domain","volume":"106","author":"Ghosal","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.neurobiolaging.2014.02.005","article-title":"Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer\u2019s disease and facilitates APP\/BACE1 interactions","volume":"35","author":"Fabelo","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.neurobiolaging.2013.02.001","article-title":"Inhibition of serine palmitoyltransferase reduces A\u03b2 and Tau hyperphosphorylation in a murine model: A safe therapeutic strategy for Alzheimer\u2019s disease","volume":"34","author":"Geekiyanage","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/bj3540047","article-title":"Caveolae\/lipid rafts in fibroblast-like synoviocytes: Ectopeptidase-rich membrane microdomains","volume":"354","author":"Riemann","year":"2001","journal-title":"Biochem. J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","article-title":"Dimeric amyloid \u03b2 protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated Tau accumulation in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"24","author":"Kawarabayashi","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1326-3-22","article-title":"Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to A\u03b2 and insulin degradation","volume":"3","author":"Bulloj","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.0609621104","article-title":"Cellular prion protein regulates \u03b2-secretase cleavage of the Alzheimer\u2019s amyloid precursor protein","volume":"104","author":"Parkin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neuron.2005.08.016","article-title":"The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2","volume":"47","author":"Prybylowski","year":"2005","journal-title":"Neuron"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4161\/pri.22212","article-title":"Amyloid-\u03b2 induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease","volume":"7","author":"Um","year":"2013","journal-title":"Prion"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of Tau pathology in a model of early Alzheimer\u2019s disease","volume":"73","author":"Polydoro","year":"2012","journal-title":"Neuron"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.neurobiolaging.2010.01.011","article-title":"Early neuronal dysfunction by amyloid \u03b2 oligomers depends on activation of NR2B-cnotaining NMDA receptors","volume":"32","author":"Ronicke","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1096\/fj.07-9766com","article-title":"Membrane-bound \u03b2-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism","volume":"22","author":"Williamson","year":"2008","journal-title":"FASEB J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1523\/JNEUROSCI.0395-10.2010","article-title":"Memory impairment in transgenic Alzheimer mice requires cellular prion protein","volume":"30","author":"Gimbel","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.0911829107","article-title":"Synthetic amyloid-\u03b2 oligomers impair long-term memory independently of cellular prion protein","volume":"107","author":"Balducci","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/emmm.201000082","article-title":"Prion protein and A\u03b2-related synaptic toxicity impairment","volume":"2","author":"Calella","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/hmg\/ddr542","article-title":"Cellular prion protein is essential for oligomeric amyloid-\u03b2-induced neuronal cell death","volume":"21","author":"Kudo","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1038\/ncomms3416","article-title":"Amyloid-\u03b2 nanotubes are associated with prion protein-dependent synaptotoxicity","volume":"4","author":"Nicoll","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JAD-2009-0933","article-title":"Tau phosphorylation by Cdk5 and Fyn in response to amyloid peptide Abera (25\u201335): Involvement of lipid rafts","volume":"16","author":"Hernandez","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bbrc.2006.05.087","article-title":"Recruitment of active glycogen synthase kinase-3 into neuronal lipid rafts","volume":"345","author":"Sui","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1101\/gad.10.7.816","article-title":"The Cdk5\/p35 kinase is essential for neurite outgrowth during neuronal differentiation","volume":"10","author":"Nikolic","year":"1996","journal-title":"Genes Dev."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fnmol.2014.00065","article-title":"Physiological and pathological phosphorylation of Tau by Cdk5","volume":"7","author":"Kimura","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.arcmed.2012.10.015","article-title":"Deregulated Cdk5 activity is involved in inducing Alzheimer\u2019s disease","volume":"43","author":"Shukla","year":"2012","journal-title":"Arch. Med. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrd2111","article-title":"Untangling Tau hyperphosphorylation in drug design for neurodegenerative diseases","volume":"6","author":"Mazanetz","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","article-title":"Phosphorylation of Tau by fyn: Implications of Alzheimer\u2019s disease","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"35119","DOI":"10.1074\/jbc.M505895200","article-title":"Disease-related modifications in Tau affect the interaction between Fyn and Tau","volume":"280","author":"Bhaskar","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of Tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1111\/j.1742-4658.2011.08218.x","article-title":"Tyrosine phosphorylation of Tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau","volume":"278","author":"Usardi","year":"2011","journal-title":"FEBS J."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and Tau pathology in Alzheimer\u2019s disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1523\/JNEUROSCI.2350-05.2005","article-title":"Energy inhibition elevates \u03b2-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: Possible early events in Alzheimer\u2019s disease pathogenesis","volume":"25","author":"Velliquette","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuron.2008.10.047","article-title":"Phosphorylation of the translation initiation factor eIF2\u03b1 increases BACE1 levels and promotes amyloidogenesis","volume":"60","author":"Sadleir","year":"2008","journal-title":"Neuron"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"S579","DOI":"10.3233\/JAD-2010-100327","article-title":"Rethinking Alzheimer\u2019s disease therapy: Are mitochondria the key?","volume":"20","author":"Ankarcrona","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bbrc.2010.12.080","article-title":"O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-\u03b2 precursor protein (APP)","volume":"404","author":"Jacobsen","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1471-4159.2004.02389.x","article-title":"Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism","volume":"89","author":"Liu","year":"2004","journal-title":"J. Neurochem."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1021\/ja407156m","article-title":"OGlcNAcylation and phosphorylation have opposing structural effects in Tau: Phosphothreonine induces particular conformational order","volume":"136","author":"Brister","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbadis.2004.09.008","article-title":"Tau pathology in Alzheimer disease and other tauopathies","volume":"1739","author":"Iqbal","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1073\/pnas.0400348101","article-title":"O-GlcNAcylation regulates phosphorylation of Tau: A mechanism involved in Alzheimer\u2019s disease","volume":"101","author":"Liu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1074\/jbc.M807431200","article-title":"In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation","volume":"284","author":"Tallent","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adh. Migr."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbadis.2011.10.003","article-title":"Elevation of glutathione as a therapeutic strategy in Alzheimer disease","volume":"1822","author":"Pocernich","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0891-5849(99)00269-5","article-title":"Age-associated decline in \u03b3-glutamylcysteine synthetase gene expression in rats","volume":"28","author":"Liu","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3233\/JAD-132483","article-title":"The emerging role of glutathione in Alzheimer\u2019s disease","volume":"40","author":"Saharan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1096\/fj.09-149997","article-title":"Depletion of GSH in glial cells induces neurotoxicity: Relevance to aging and degenerative neurological diseases","volume":"24","author":"Lee","year":"2010","journal-title":"FASEB J."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"17721","DOI":"10.1074\/jbc.M800013200","article-title":"Hydrogen peroxide promotes A\u03b2 production through JNK-dependent activation of \u03b3-secretase","volume":"283","author":"Shen","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2353\/ajpath.2006.051223","article-title":"\u03b2-amyloid mediated nitration of manganese superoxide dismutase: Implication for oxidative stress in a APPNLH\/NLH X PS-1P264L\/P264L double knock-in mouse model of Alzheimer\u2019s disease","volume":"168","author":"Anantharaman","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer\u2019s disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","article-title":"Characterization of copper interactions with Alzheimer amyloid \u03b2 peptides: Identification of an attomolar-affinity copper binding site on amyloid \u03b21-42","volume":"75","author":"Atwood","year":"2000","journal-title":"J. Neurochem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.274.52.37111","article-title":"Cu(II) potentiation of Alzheimer A\u03b2 neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction","volume":"274","author":"Huang","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/2051-5960-1-83","article-title":"A central role for dityrosine crosslinking of amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"1","author":"Williams","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1523\/JNEUROSCI.18-20-08126.1998","article-title":"Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation","volume":"18","author":"Hensley","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"19439","DOI":"10.1074\/jbc.C000165200","article-title":"Evidence that the \u03b2-amyloid plaques of Alzheimer\u2019s disease represent the redox-silencing and entombment of A\u03b2 by zinc","volume":"275","author":"Cuajungco","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"e33552","DOI":"10.1371\/journal.pone.0033552","article-title":"The zinc dyshoemostasis hypothesis of Alzheimer\u2019s disease","volume":"7","author":"Craddock","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-\u03b2 peptide neurotoxicity in Alzheimer\u2019s disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J. Mol. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neurobiolaging.2009.04.016","article-title":"Advanced glycation endproducts and their receptor RAGE in Alzheimer\u2019s disease","volume":"32","author":"Srikanth","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2009.09.008","article-title":"Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer\u2019s disease and diabetes mellitus","volume":"37","author":"Valente","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1096\/fj.08-126383","article-title":"RAGE regulates BACE1 and A\u03b2 generation via NFAT1 activation in Alzheimer\u2019s disease animal model","volume":"23","author":"Cho","year":"2009","journal-title":"FASEB J."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3233\/JAD-2009-1030","article-title":"RAGE and Alzheimer\u2019s disease: A progression factor for amyloid-\u03b2-induced cellular perturbation?","volume":"16","author":"Yan","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)12462-9","article-title":"Blood\u2013brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer\u2019s amyloid \u03b2 in guinea pigs","volume":"206","author":"Martel","year":"1996","journal-title":"Neurosci. Lett."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumlation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/mp.2010.17","article-title":"Linking Alzheimer\u2019s disease to insulin resistance: The FoxO response to oxidative stress","volume":"15","author":"Manolopoulos","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.redox.2013.01.002","article-title":"Oxidative modification of lipoic acid by HNE in Alzheimer disease brain","volume":"1","author":"Hardas","year":"2013","journal-title":"Redox Biol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/bi061853s","article-title":"The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation","volume":"46","author":"Siegel","year":"2007","journal-title":"Biochemistry"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","article-title":"Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer\u2019s disease","volume":"19","author":"Markesbery","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain: Review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1073\/pnas.94.9.4772","article-title":"Insulin-like growth factor I protects and rescues hippocampal neurons against \u03b2-amyloid- and human amylin-induced toxicity","volume":"94","author":"Dore","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrn3209","article-title":"The many faces of insulin-like peptide signalling in the brain","volume":"13","author":"Fernandez","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-0186(93)90062-A","article-title":"The cellular and physiological actions of insulin in the central nervous system","volume":"22","author":"Wozniak","year":"1993","journal-title":"Neurochem. Int."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1096\/fj.01-0009rev","article-title":"Defects of the isnulin receptor substrate (IRS) system in human metabolic disorders","volume":"15","author":"Sesti","year":"2001","journal-title":"FASEB J."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1126\/science.1092952","article-title":"Insulin signaling in health and disease","volume":"302","author":"White","year":"2003","journal-title":"Science"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1523\/JNEUROSCI.23-18-07084.2003","article-title":"Insulin receptor substrate-2 deficiency impairs brain growth and promotes Tau phosphorylation","volume":"23","author":"Schubert","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1210\/en.2005-0063","article-title":"Tau is hyperphosphorylated in the insulin-like growth factor-I null brain","volume":"146","author":"Cheng","year":"2005","journal-title":"Endocrinology"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbrc.2009.06.032","article-title":"Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice","volume":"386","author":"Killick","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0959-437X(98)80062-2","article-title":"Mechanism of activation and function of protein kinase B","volume":"8","author":"Alessi","year":"1998","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J. Neural Transm."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1074\/jbc.M101521200","article-title":"Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action","volume":"277","author":"Aguirre","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"29911","DOI":"10.1074\/jbc.272.47.29911","article-title":"A molecular basis for insulin resistance. Elevated serine\/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin and impairs their ability to undergo insulin-induced tyrosine phosphorylation","volume":"272","author":"Paz","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_204","first-page":"S26","article-title":"How does brain insulin resistance develop in Alzheimer\u2019s disease?","volume":"10","author":"Lourenco","year":"2014","journal-title":"Alzheimers Dement."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","article-title":"Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain","volume":"1842","author":"Butterfield","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1101\/lm.88005","article-title":"Insulin receptor signaling in long-term memory consolidation following spatial learning","volume":"12","author":"Dou","year":"2005","journal-title":"Learn. Mem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2006.08.009","article-title":"The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer\u2019s disease","volume":"42","author":"Cole","year":"2007","journal-title":"Exp. Gerontol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","article-title":"Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric A\u03b2","volume":"284","author":"Zhao","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","article-title":"Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: Implications for Alzheimer\u2019s disease intervention","volume":"24","author":"Zhao","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-\u03b2 in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsiron4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.neurobiolaging.2007.04.013","article-title":"Neocortical glial cell numbers in human brains","volume":"29","author":"Pelvig","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00401-014-1321-z","article-title":"Microglia as a critical player in both developmental and late-life CNS pathogenesis","volume":"128","author":"Derecki","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"13632","DOI":"10.1073\/pnas.2234031100","article-title":"Inflammation is detrimental for neurogenesis in adult brain","volume":"100","author":"Ekdahl","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1088417","article-title":"Inflammatory blockade restores adult hippocampal neurogenesis","volume":"302","author":"Monje","year":"2003","journal-title":"Science"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nn1629","article-title":"Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood","volume":"9","author":"Ziv","year":"2006","journal-title":"Nat. Neurosci."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on Tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","article-title":"Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia","volume":"95","author":"Harrison","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jnr.10304","article-title":"Fractalkine and fractalkine receptors in human neurons and glial cells","volume":"69","author":"Hatori","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nn0706-859","article-title":"Fractalkine: Moving from chemotaxis to neuroprotection","volume":"9","author":"Re","year":"2006","journal-title":"Nat. Neurosci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1471-4159.2009.06253.x","article-title":"Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attenuates microglial activation in vivo and in vitro","volume":"110","author":"Lyons","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1111\/j.1460-9568.2004.03800.x","article-title":"Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation","volume":"20","author":"Deiva","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2005.03.023","article-title":"Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity","volume":"166","author":"Limatola","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neulet.2008.03.019","article-title":"Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"436","author":"Kim","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"32713","DOI":"10.1074\/jbc.M111.254268","article-title":"CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease","volume":"286","author":"Cho","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1523\/JNEUROSCI.1781-07.2007","article-title":"CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: A role for IL-4","volume":"27","author":"Lyons","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.2174\/1381612820666140130202911","article-title":"Brain innate immunity in the regulation of neuroinflammation: Therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system","volume":"20","author":"Hernangomez","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbi.2011.10.004","article-title":"CD200 fusion protein decreases microglial activation in the hippocampus of aged rats","volume":"26","author":"Cox","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neurobiolaging.2005.03.013","article-title":"mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging","volume":"27","author":"Frank","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2008.09.003","article-title":"Decreased expression of CD200 and CD200 receptor in Alzheimer\u2019s disease: A potential mechanism leading to chronic inflammation","volume":"215","author":"Walker","year":"2009","journal-title":"Exp. Neurol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"34722","DOI":"10.1074\/jbc.M111.280826","article-title":"Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: A role for Toll-like receptor activation","volume":"286","author":"Costello","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12017-009-8099-5","article-title":"Involvement of Fc receptors in disorders of the central nervous system","volume":"12","author":"Okun","year":"2010","journal-title":"Neuromol. Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2353\/ajpath.2009.090147","article-title":"Signal regulatory protein-\u03b21: A microglial modulator of phagocytosis in Alzheimer\u2019s disease","volume":"175","author":"Gaikwad","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","article-title":"Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Doens","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1074\/jbc.272.10.6641","article-title":"Degradation of amyloid \u03b2-protein by a metalloprotease secreted by microglia and other neural and non-neural cells","volume":"272","author":"Qiu","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2002.00855.x","article-title":"\u03b2-amyloid catabolism: Roles for neprilysin (NEP) and other metallopeptidases?","volume":"81","author":"Carson","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neulet.2008.07.019","article-title":"Possible involvement of cathepsin B released by microglia in methylmercury-induced cerebellar pathological changes in the adult rat","volume":"442","author":"Sakamoto","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","article-title":"Microglial dysfunction in brain aging and Alzheimer\u2019s disease","volume":"88","author":"Mosher","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuron.2013.06.046","article-title":"Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer\u2019s disease","volume":"79","author":"Lucin","year":"2013","journal-title":"Neuron"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-065X.2011.01042.x","article-title":"Deregulated inflammasome signaling in disease","volume":"243","author":"Lamkanfi","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","article-title":"Microglial phagocytosis induced by fibrillar \u03b2-amyloid and IgGs are differentially regulated by proinflammatory cytokines","volume":"25","author":"Landreth","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.mad.2013.10.001","article-title":"The glia doctorine: Addressing the role of glial cells in healthy brain ageing","volume":"134","author":"Nagelhus","year":"2013","journal-title":"Mech. Ageing Dev."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"e92325","DOI":"10.1371\/journal.pone.0092325","article-title":"Human astrocytes: Secretome profiles of cytokines and chemokines","volume":"9","author":"Choi","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0079-6123(01)32087-3","article-title":"Glial diffusion barriers during aging and pathological states","volume":"132","author":"Sykova","year":"2001","journal-title":"Prog. Brain Res."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Vargova, L., and Sykova, E. (2014). Astrocytes and extracellular matrix in extrasynaptic volume transmission. Philos. Trans. R. Soc. Lond. B, 369.","DOI":"10.1098\/rstb.2013.0608"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1566524043479185","article-title":"Astrocyte influences on ischemic neuronal death","volume":"4","author":"Swanson","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0074-7742(07)82005-8","article-title":"The role of astrocytes and complement system in neural plasticity","volume":"82","author":"Pekny","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-8993(00)03176-0","article-title":"\u0392-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology","volume":"894","author":"Apelt","year":"2001","journal-title":"Brain Res."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2165\/00023210-200317090-00004","article-title":"The glutamatergic system and Alzheimer\u2019s disease: Therapeutic implications","volume":"17","author":"Butterfield","year":"2003","journal-title":"CNS Drugs"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer\u2019s disease brain: The role of A\u03b21-42","volume":"78","author":"Lauderback","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.410400512","article-title":"Deficient glutamate transport is associated with neurodegeneration in Alzheimer\u2019s disease","volume":"40","author":"Masliah","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1096\/fj.05-3748fje","article-title":"Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: A mechanism mediated by tumor necrosis factor-\u03b1","volume":"19","author":"Korn","year":"2005","journal-title":"FASEB J."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.neuint.2009.12.021","article-title":"Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons","volume":"56","author":"Zou","year":"2010","journal-title":"Neurochem. Int."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1326-6-55","article-title":"Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer\u2019s disease mouse model: Mechanism of deficient glutamategic transmission?","volume":"6","author":"Olabarria","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1469-7580.2012.01536.x","article-title":"Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"221","author":"Verkhratsky","year":"2012","journal-title":"J. Anat."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nbd.2014.08.031","article-title":"Astrocytes and microglia but not neurons preferentially generate N-terminally truncated A\u03b2 peptides","volume":"73","author":"Oberstein","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","article-title":"Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-\u03b2 peptide catabolism","volume":"26","author":"Yin","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(03)00898-X","article-title":"Human neprilysin is capable of degrading amyloid \u03b2 peptide not only in the monomeric form but also the pathological oligomeric form","volume":"350","author":"Kanemitsu","year":"2003","journal-title":"Neurosci. Lett."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1042\/BST0331101","article-title":"A\u03b2-degrading enzymes: Modulators of Alzheimer\u2019s disease pathogenesis and targets for therapeutic intervention","volume":"33","author":"Eckman","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1073\/pnas.82.1.203","article-title":"Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets","volume":"82","author":"Elshourbagy","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3940(96)12716-6","article-title":"Expression of apolipoprotein E mRNA in rat microglia","volume":"211","author":"Nakai","year":"1996","journal-title":"Neurosci. Lett."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: Insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Holtzman, D.M., Herz, J., and Bu, G. (2012). Apolipoprotein E and apolipoprotein E receptors: Normal biology and role in Alzheimer disease. Cold Spring Harb. Perspect. Med., 2.","DOI":"10.1101\/cshperspect.a006312"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1074\/jbc.M111.288746","article-title":"Low-density lipoprotein receptor represent an apolipoprotein E-independent pathway of A\u03b2 uptake and degradation by astrocytes","volume":"287","author":"Basak","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11357-008-9050-7","article-title":"Evidence of DNA damage in Alzheimer disease: Phosphorylation of histone H2AX in astrocytes","volume":"30","author":"Myung","year":"2008","journal-title":"Age"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"e45069","DOI":"10.1371\/journal.pone.0045069","article-title":"Astrocyte senescence as a component of Alzheimer\u2019s disease","volume":"7","author":"Bhat","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal \u03b2-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.5620-07.2008","article-title":"Lack of pathology in a triple transgenic mouse model of Alzheimer\u2019s disease after overexpression of the anti-apoptotic protein Bcl-2","volume":"28","author":"Rohn","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0006-8993(97)00370-3","article-title":"Behavioural performance in three substrains of mouse strain 129","volume":"762","author":"Montkowski","year":"1997","journal-title":"Brain Res."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(99)01586-3","article-title":"A behavioral and neuroanatomical assessment of an inbred substrain of 129 mice with behavioral comparisons to C57BL\/6J mice","volume":"836","author":"Balogh","year":"1999","journal-title":"Brain Res."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0166-2236(96)20020-7","article-title":"Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype?","volume":"19","author":"Gerlai","year":"1996","journal-title":"Trends Neurosci."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(97)00673-2","article-title":"Assessing the effects of the 129\/Sc genetic background on swimming navigation learning in transgenic mutants: A study using mice with a modified \u03b2-amyloid precursor protein gene","volume":"771","author":"Wolfer","year":"1997","journal-title":"Brain Res."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11064-009-9922-y","article-title":"Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice","volume":"34","author":"Takeda","year":"2009","journal-title":"Neurochem. Res."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.exger.2011.02.006","article-title":"Age-related autophagy alterations in the brain of senescence accelerated mouse prone 8 (SAMP8) mice","volume":"46","author":"Ma","year":"2011","journal-title":"Exp. Gerontol."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10522-005-6041-2","article-title":"Elevated oxidative stress in the brain of senescence-accelerated mice at 5 months of age","volume":"7","author":"Sierra","year":"2006","journal-title":"Biogerontology"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2174\/138161212799315795","article-title":"The SAMP8 mouse: A model to develop therapeutic interventions for Alzheimer\u2019s disease","volume":"18","author":"Morley","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2009.09.001","article-title":"Amelioration of cognitive ability in senescence-accelerated mouse prone 8 (SAMP8) by intra-bone marrow-bone marrow transplantation","volume":"465","author":"Li","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.pneurobio.2010.01.002","article-title":"Epigenetic regulation in the pathophysiology of Alzheimer\u2019s disease","volume":"90","author":"Chouliaras","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","article-title":"Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer\u2019s disease mouse model through modulation of neuroinflammation","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3727\/096368912X640556","article-title":"Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model","volume":"21","author":"Park","year":"2012","journal-title":"Cell Transpl."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12015-013-9443-6","article-title":"Progress in stem cell therapy for major human neurological disorders","volume":"9","author":"Revilla","year":"2013","journal-title":"Stem Cell Rev."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/stem.1812","article-title":"Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS","volume":"32","author":"Forostyak","year":"2014","journal-title":"Stem Cells"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-444-59544-7.00016-0","article-title":"Transplantation of mesenchymal stem cells in ALS","volume":"201","author":"Mazzini","year":"2012","journal-title":"Prog. Brain Res."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1172\/JCI62516","article-title":"Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques","volume":"123","author":"Hayashi","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2013.03.016","article-title":"Mesenchymal stem cells and neuroregeneration in Parkinson\u2019s disease","volume":"247","author":"Bohn","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00441-007-0509-0","article-title":"Abdallah, B.M. Human bone-marrow-derived mesenchymal stem cells: Biological characteristics and potential role in therapy of degenerative diseases","volume":"331","author":"Kassem","year":"2008","journal-title":"Cell Tissue Res."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1634\/stemcells.22-5-649","article-title":"Human placenta-derived cells have mesenchymal stem\/progenitor cell potential","volume":"22","author":"Fukuchi","year":"2004","journal-title":"Stem Cells"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/ijms15021719","article-title":"Use of genetically modified mesenchymal stem cells to treat neurodegenerative diseases","volume":"15","author":"Wyse","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3171\/2008.9.JNS08158","article-title":"Intravenous mesenchymal stem cell therapy for traumatic brain injury","volume":"110","author":"Harting","year":"2009","journal-title":"J. Neurosurg."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","article-title":"Intranasal delivery of cells to the brain","volume":"88","author":"Danielyan","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/BRS.0b013e31819403ce","article-title":"Grafting of human bone marrow stromal cells into spinal cord injury: A comparison of delivery methods","volume":"34","author":"Paul","year":"2009","journal-title":"Spine"},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"11275","DOI":"10.3390\/ijms150711275","article-title":"Human mesenchymal stem cells modulate inflammatory cytokines after spinal cord injury in rat","volume":"15","author":"Urdzikova","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"e958","DOI":"10.1038\/cddis.2013.490","article-title":"Placenta-derived mesenchymal stem cells improve memory dysfunction in an A\u03b21-42-induced mouse model of Alzheimer\u2019s disease","volume":"4","author":"Yun","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fcell.2014.00016","article-title":"Stem cell transplantation improves aging-related disease","volume":"2","author":"Ikehara","year":"2014","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2008.11.059","article-title":"Bone marrow-derived mesenchymal stem cells reduce brain amyloid-\u03b2 deposition and accelerate the activation of microglia in an acutely induced Alzheimer\u2019s disease mouse model","volume":"450","author":"Lee","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/stem.277","article-title":"Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-\u03b2 deposition and rescues memory deficits in Alzheimer\u2019s disease mice by modulation of immune responses","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2005.03.005","article-title":"Activation of microglia by aggregated \u03b2-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-\u03b3 and IL-4 render them protective","volume":"29","author":"Butovsky","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1073\/pnas.0604681103","article-title":"Glatiramer acetate fights against Alzheimer\u2019s disease by inducing dendritic-like microglia expression insulin-like growth factor 1","volume":"103","author":"Butovsky","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat. Med."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/stem.1240","article-title":"Can stem cells be used to treat or model Alzheimer disease?","volume":"30","author":"Chen","year":"2012","journal-title":"Stem Cells"},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/cdd.2013.158","article-title":"Immunobiology of mesenchymal stem cells","volume":"21","author":"Ma","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/neu.2006.3771","article-title":"Transplantation of adult rat spinal cord stem\/progenitor cells for spinal cord injury","volume":"24","author":"Parr","year":"2007","journal-title":"J. Neurotrauma"},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"18171","DOI":"10.1073\/pnas.0508945102","article-title":"Human stem\/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice","volume":"102","author":"Munoz","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12015-010-9190-x","article-title":"Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice","volume":"7","author":"Kan","year":"2011","journal-title":"Stem Cell Rev."},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"e45757","DOI":"10.1371\/journal.pone.0045757","article-title":"The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer\u2019s disease mice","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/mp.2009.110","article-title":"Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior","volume":"15","author":"Tfilin","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tox.2010.10.011","article-title":"Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K\/Akt activation","volume":"279","author":"Lu","year":"2011","journal-title":"Toxicology"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.8178174","article-title":"Long-distance neuronal migration in the adult mammalian brain","volume":"264","author":"Lois","year":"1994","journal-title":"Science"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/35067582","article-title":"A unified hypothesis on the lineage of neural stem cells","volume":"2","author":"Tramontin","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/cne.1040","article-title":"Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus","volume":"435","author":"Cameron","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2008.01.033","article-title":"Mechanisms and functional implications of adult neurogenesis","volume":"132","author":"Zhao","year":"2008","journal-title":"Cell"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1523\/JNEUROSCI.6003-08.2009","article-title":"Neural stem and progenitor cells retain their potential for proliferation and differentiation into functional neurons despite lower number in aged brain","volume":"29","author":"Ahlenius","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1474-9726.2012.00816.x","article-title":"Aging brain microenvironment decreases hippocampal neurogenesis through Wnt-mediated survivin signaling","volume":"11","author":"Miranda","year":"2012","journal-title":"Aging Cell"},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbr.2011.10.009","article-title":"New neurons in an aged brain","volume":"227","author":"Lee","year":"2012","journal-title":"Behav. Brain Res."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"14394","DOI":"10.1523\/JNEUROSCI.3836-09.2009","article-title":"Telomere shortening in neural stem cells disrupts neuronal differentiation and neuritogenesis","volume":"29","author":"Ferron","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cell improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Kitazawa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1567205054367919","article-title":"Possible use of autologous stem cell therapies for Alzheimer\u2019s disease","volume":"2","author":"Sugaya","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1007\/s00018-008-8053-y","article-title":"Behavior of neural stem cells in the Alzheimer brain","volume":"65","author":"Waldau","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000233256","article-title":"Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures","volume":"24","author":"Rivera","year":"2009","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a toll like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","article-title":"CD14 and Toll-like receptors 2 and 4 are required for fibrillar A\u03b2-stimulated microglial activation","volume":"29","author":"Savage","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ajpath.2011.05.045","article-title":"MyD88 deficiency ameliorates \u03b2-amyloidosis in an animal model of AD","volume":"179","author":"Lim","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_333","doi-asserted-by":"crossref","unstructured":"Malm, T., Koistinaho, J., and Kanninen, K. (2011). Utilization of APPswe\/PS1dE9 transgenic mice in research of Alzheimer\u2019s disease: Focus on gene therapy and cell-based therapy applications. Int. J. Alzheimers Dis., 2011.","DOI":"10.4061\/2011\/517160"},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/329065a0","article-title":"Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor","volume":"329","author":"Fischer","year":"1987","journal-title":"Nature"},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-8993(97)01525-4","article-title":"Permeability of the blood-brain barrier to neurotrophins","volume":"788","author":"Pan","year":"1998","journal-title":"Brain Res."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-4886(91)90143-Z","article-title":"Hypophagia is induced by intracerebroventricular administration of nerve growth factor","volume":"113","author":"Williams","year":"1991","journal-title":"Exp. Neurol."},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat. Med."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jalz.2013.09.004","article-title":"A phase 1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer\u2019s disease","volume":"10","author":"Rafii","year":"2014","journal-title":"Alzheimers Dement."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm.1912","article-title":"Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer\u2019s disease","volume":"15","author":"Nagahara","year":"2009","journal-title":"Nat. Med."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0169-328X(97)00125-3","article-title":"Brain-derived neurotrophic factor is reduced in Alzheimer\u2019s disease","volume":"49","author":"Connor","year":"1997","journal-title":"Mol. Brain Res."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/scrt440","article-title":"Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models","volume":"5","author":"Spencer","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1101\/gad.173922.111","article-title":"Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state","volume":"25","author":"Lapasset","year":"2011","journal-title":"Genes Dev."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"e41572","DOI":"10.1371\/journal.pone.0041572","article-title":"Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research","volume":"7","author":"Yagi","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","article-title":"Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells","volume":"20","author":"Yagi","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10821","article-title":"Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells","volume":"482","author":"Israel","year":"2012","journal-title":"Nature"},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.nbt.2014.04.004","article-title":"iPSCs, aging and age-related diseases","volume":"31","author":"Isobe","year":"2014","journal-title":"N. Biotechnol."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nchembio.2007.38","article-title":"Telomere length, stem cells and aging","volume":"3","author":"Blasco","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2008.12.010","article-title":"Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells","volume":"4","author":"Marion","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/cr.2011.16","article-title":"Association of telomere length with authentic pluripotency of ES\/iPS cells","volume":"21","author":"Huang","year":"2011","journal-title":"Cell Res."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/alzrt5","article-title":"Proteinopathy-induced neuronal senescence: A hypothesis for brain failure in Alzheimer\u2019s and other neurodegenerative diseases","volume":"1","author":"Golde","year":"2009","journal-title":"Alzheimers Res. Ther."},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12035-013-8445-3","article-title":"The senescence hypothesis of disease progression in Alzheimer\u2019s disease: An integrated matrix of disease pathways for FAD and SAD","volume":"48","author":"Hunter","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1037\/0735-7044.103.1.61","article-title":"Brain transplants enhance rather than reduce the impairment of spatial memory and olfaction in bulbectomized rats","volume":"103","author":"Amemori","year":"1989","journal-title":"Behav. Neurosci."},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: Procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/11\/25961\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:51:27Z","timestamp":1760215887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/16\/11\/25961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":354,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11]]}},"alternative-id":["ijms161125961"],"URL":"https:\/\/doi.org\/10.3390\/ijms161125961","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}